|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dworkin AM, Huang TH and Toland AE:
Epigenetic alterations in the breast: Implications for breast
cancer detection, prognosis and treatment. Semin Cancer Biol.
19:165–171. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jovanovic J, Rønneberg JA, Tost J and
Kristensen V: The epigenetics of breast cancer. Mol Oncol.
4:242–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Polyak K: Breast cancer: Origins and
evolution. J Clin Invest. 117:3155–3163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ding LH, Ye QN, Lu QJ, Zhu JH, Yan JH,
Wang ZH and Huang CF: Expression of XBP-1 in breast cancer cell
lines and its role in ERalpha signaling. Yi Chuan Xue Bao.
31:380–384. 2004.In Chinese. PubMed/NCBI
|
|
8
|
Katzenellenbogen BS: Estrogen receptors:
Bioactivities and interactions with cell signaling pathways. Biol
Reprod. 54:287–293. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Katzenellenbogen BS, Montano MM, Ekena K,
Herman ME, McInerney EM and William L: McGuire Memorial Lecture.
Antiestrogens: Mechanisms of action and resistance in breast
cancer. Breast Cancer Res Treat. 44:23–38. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Horwitz KB and McGuire WL: Estrogen
control of progesterone receptor in human breast cancer:
Correlation with nuclear processing of estrogen receptor. J Biol
Chem. 253:2223–2228. 1978.PubMed/NCBI
|
|
11
|
Shang Y, Hu X, DiRenzo J, Lazar MA and
Brown M: Cofactor dynamics and sufficiency in estrogen
receptor-regulated transcription. Cell. 103:843–852. 2000.
View Article : Google Scholar
|
|
12
|
Shang Y and Brown M: Molecular
determinants for the tissue specificity of SERMs. Science.
295:2465–2468. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carroll JS, Meyer CA, Song J, Li W,
Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC,
Hall GF, et al: Genome-wide analysis of estrogen receptor binding
sites. Nat Genet. 38:1289–1297. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lippman M, Bolan G and Huff K: The effects
of estrogens and antiestrogens on hormone-responsive human breast
cancer in long-term tissue culture. Cancer Res. 36:4595–4601.
1976.PubMed/NCBI
|
|
15
|
Irizarry R, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smyth GK: limma: Linear models for
microarray data. Bioinformatics and Computational Biology Solutions
Using R and Bioconductor. Gentleman R, Carey VJ, Huber W, Irizarry
RA and Dudoit S: 1st edition. Springer; New York, NY, USA: pp.
397–420. 2005, View Article : Google Scholar
|
|
17
|
Langfelder P and Horvath S: Fast R
functions for robust correlations and hierarchical clustering. J
Stat Softw. 46:pii: i11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Langmead B, Trapnell C, Pop M and Salzberg
SL: Ultrafast and memory-efficient alignment of short DNA sequences
to the human genome. Genome Biol. 10:R252009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng J, Liu T and Zhang Y: Using MACS to
identify peaks from ChIP-Seq data. Curr Protoc Bioinformatics
Chapter 2: Unit 2. 14:2011. View Article : Google Scholar
|
|
20
|
Zhang Y, Liu T, Meyer CA, Eeckhoute J,
Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W and
Liu XS: Model-based analysis of ChIP-Seq (MACS). Genome Biol.
9:R1372008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shin H, Liu T, Manrai AK and Liu XS: CEAS:
Cis-regulatory element annotation system. Bioinformatics.
25:2605–2606. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Grober OM, Mutarelli M, Giurato G, Ravo M,
Cicatiello L, De Filippo MR, Ferraro L, Nassa G, Papa MF, Paris O,
et al: Global analysis of estrogen receptor beta binding to breast
cancer cell genome reveals an extensive interplay with estrogen
receptor alpha for target gene regulation. BMC Genomics. 12:362011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang S, Sun H, Ma J, Zang C, Wang C, Wang
J, Tang Q, Meyer CA, Zhang Y and Liu XS: Target analysis by
integration of transcriptome and ChIP-seq data with BETA. Nat
Protoc. 8:2502–2515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moskow JJ, Bullrich F, Huebner K, Daar IO
and Buchberg AM: Meis1, a PBX1-related homeobox gene involved in
myeloid leukemia in BXH-2 mice. Mol Cell Biol. 15:5434–5443. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mahmoud AI, Kocabas F, Muralidhar SA,
Kimura W, Koura AS, Thet S, Porrello ER and Sadek HA: Meis1
regulates postnatal cardiomyocyte cell cycle arrest. Nature.
497:249–253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Doolan P, Clynes M, Kennedy S, Mehta JP,
Germano S, Ehrhardt C, Crown J and O'Driscoll L: TMEM25, REPS2 and
Meis 1: Favourable prognostic and predictive biomarkers for breast
cancer. Tumour Biol. 30:200–209. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lehmann BD, Bauer JA, Chen X, Sanders ME,
Chakravarthy AB, Shyr Y and Pietenpol JA: Identification of human
triple-negative breast cancer subtypes and preclinical models for
selection of targeted therapies. J Clin Invest. 121:2750–2767.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Merlo A, Casalini P, Carcangiu ML,
Malventano C, Triulzi T, Mènard S, Tagliabue E and Balsari A: FOXP3
expression and overall survival in breast cancer. J Clin Oncol.
27:1746–1752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Polanczyk MJ, Hopke C, Huan J, Vandenbark
AA and Offner H: Enhanced FoxP3 expression and Treg cell function
in pregnant and estrogen-treated mice. J Neuroimmunol. 170:85–92.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fox SB, Brown P, Han C, Ashe S, Leek RD,
Harris AL and Banham AH: Expression of the forkhead transcription
factor FOXP1 is associated with estrogen receptor alpha and
improved survival in primary human breast carcinomas. Clin Cancer
Res. 10:3521–3527. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ling Y, Xu X, Hao J, Ling X, Du X, Liu X
and Zhao X: Aberrant methylation of the THRB gene in tissue and
plasma of breast cancer patients. Cancer Genet Cytogenet.
196:140–145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Baniahmad A, Ha I, Reinberg D, Tsai S,
Tsai MJ and O'Malley BW: Interaction of human thyroid hormone
receptor beta with transcription factor TFIIB may mediate target
gene derepression and activation by thyroid hormone. Proc Natl Acad
Sci USA. 90:8832–8836. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fabian J, Lodrini M, Schier M, Thole T,
Kopp-Schneider A, Capper D, von Deimling A, Oehme I, Wiegand I,
Milde T, et al: GRHL1 inhibits tumorigenicity and is a prognostic
marker in neuroblastoma. Klin Padiatr. 225:A292013. View Article : Google Scholar
|
|
34
|
Fabian J, Lodrini M, Oehme I, Schier MC,
Thole TM, Hielscher T, Kopp-Schneider A, Opitz L, Capper D, von
Deimling A, et al: GRHL1 acts as tumor suppressor in neuroblastoma
and is negatively regulated by MYCN and HDAC3. Cancer Res.
74:2604–2616. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tao J, Kuliyev E, Wang X, Li X, Wilanowski
T, Jane SM, Mead PE and Cunningham JM: BMP4-dependent expression of
Xenopus Grainyhead-like 1 is essential for epidermal
differentiation. Development. 132:1021–1034. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
de la Garza G, Schleiffarth JR, Dunnwald
M, Mankad A, Weirather JL, Bonde G, Butcher S, Mansour TA, Kousa
YA, Fukazawa CF, et al: Interferon regulatory factor 6 promotes
differentiation of the periderm by activating expression of
grainyhead-like 3. J Invest Dermatol. 133:68–77. 2013. View Article : Google Scholar :
|
